Best Acute lymphoblastic leukemia hematologist-oncologists in Turkey: TOP 20 doctors

• Prof. MD Zafer Gulbas specializes in acute lymphoblastic leukemia (ALL) treatment and transplantation.
• ALL treatment methods include chemotherapy, targeted therapy, immunotherapy, and transplantation.
• International training at medical institutions in Israel, USA (Fred Hutchinson, M.D. Anderson), and Canada (Princess Margaret Hospital).
• Director of the Bone Marrow Transplantation Center at Anadolu Medical Center since 2005.
• Professional memberships: Turkish Society of Hematology, European Hematology Association, and American Society of Hematology.

• Specializes in acute lymphoblastic leukemia (ALL) treatment, including chemotherapy, targeted therapy, and immunotherapy.
• Has international practice experience at medical institutions in the USA, UK, Israel, and Turkey.
• Certified by the European Society of Medical Oncology (ESMO), ensuring high standards in oncology care.
• Member of ESMO and European School of Oncology (ESO), reflecting her commitment to ongoing education.
• Fluent in English and Turkish, with intermediate proficiency in Russian, which aids in patient communication.

• Specializes in treating Acute Lymphoblastic Leukemia (ALL) with tailored therapies.
• Employs chemotherapy, stem cell transplant, and targeted therapy for ALL.
• Trained in Japan, contributing to international expertise in hematology.
• Accumulated hands-on experience in one of Turkey's largest units.
• Proficient in English and Turkish, facilitating multilingual consultations.
• Offers remote consultations for patients with Acute Lymphoblastic Leukemia.
• Over 26 years of experience in Hematology, focusing on transplantation.

Prof. Baytan is a doctor who graduated from Ankara University Medical Faculty in 1992 and became a Specialist in Medicine at Uludağ University Faculty of Medicine, Department of Child Diseases. He is experienced in the diagnosis and treatment of childhood cancers, leukemia, anemia, and other diseases. He has 15 articles published in international refereed journals, 9 full texts presented and published in international scientific meetings, 3 books/book chapters written, and 8 articles published in local refereed journals.

Prof. Songul Serefhanoglu is a Hematologist at ISU Medical Park since 2019, and has been the Director and President of Adult Hematology Department of Sisli Memorial Hospital, Istanbul since 2019. He completed his Medical Education from Firat University, Elazig/Turkey (1994-2000), Internal Medicine from Inonu University, Malatya/Turkey (2001-2005), and Hematology from Hacettepe University, Ankara/Turkey (2006-2009). He has been involved in peripheral hematopoietic stem cell transplantation, with an average of 100-120/year.

Prof. Müge Gökçe is a pediatric hematologist and cancer specialist based in Turkey with expertise in transplantation. She has held positions in various hospitals since 2001 and holds degrees in general medicine, pediatrics, and pediatric hematology and oncology. She is a member of the Turkish Hematology Association, the Turkish Society of Pediatric Hematology, and the European Society for Blood and Marrow Transplantation.

Dr. Yener Koc is a highly experienced and award-winning transplant specialist, trained in the USA. He has provided over 1,900 transplants and achieved long-term survival rates of 66-90% for various conditions, with a mortality rate of 0.5-9%. He has authored over 230 scientific publications and been an inspector for the European Bone Marrow Transplant Centers since 2004.

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on " Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Cell Research Board. He is the founding president of the FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Cell Transplantation (, )

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.